相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
H. Jean Khoury et al.
BLOOD (2012)
Protein kinase C, an elusive therapeutic target?
Daria Mochly-Rosen et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
AXITINIB, A NEW THERAPEUTIC OPTION IN RENAL CELL CARCINOMA
E. R. Kessler et al.
DRUGS OF TODAY (2012)
Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism
Hee Jae Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Tyrosine kinase-independent inhibition by genistein on spermatogenic T-type calcium channels attenuates mouse sperm motility and acrosome reaction
Jin Tao et al.
CELL CALCIUM (2009)
The effect of tyrosine kinase inhibitor genistein on voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells
Eun A. Ko et al.
VASCULAR PHARMACOLOGY (2009)
1-[6-[[(17β)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122) Selectively Inhibits Kir3 and BK Channels in a Phospholipase C-Independent Fashion
Angelika Klose et al.
MOLECULAR PHARMACOLOGY (2008)
Genistein inhibits voltage-gated sodium currents in SCG neurons through protein tyrosine kinase-dependent and kinase-independent mechanisms
Zhanfeng Jia et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2008)
Molecular basis for genistein-induced inhibition of Kir2.3 currents
Zhiying Zhao et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2008)
Rottlerin induces calcium influx and protein degradation in cultured lenses independent of effects on protein kinase Cδ
Shang-Zhi Xu
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury
Grant R. Budas et al.
PHARMACOLOGICAL RESEARCH (2007)
Potent stimulation of large-conductance Ca2+-activated K+ channels by rottlerin, an inhibitor of protein kinase C-δ, in pituitary tumor (GH3) cells and in cortical neuronal (HCN-1A) cells
Sheng-Nan Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Direct modulation of Ca2+-activated K+ current by H-89 in rabbit coronary arterial smooth muscle cells
Won Sun Park et al.
VASCULAR PHARMACOLOGY (2007)
Direct inhibition of a PKA inhibitor, H-89 on KV channels in rabbit coronary arterial smooth muscle cells
YK Son et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Slowing of the inactivation of voltage-dependent sodium channels by staurosporine, the protein kinase C inhibitor, in rabbit atrial myocytes
JH Ko et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
The protein kinase A inhibitor, H-89, directly inhibits KATP and Kir channels in rabbit coronary arterial smooth muscle cells
WS Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Acceleration of K+ channel inactivation by MEK inhibitor U0126
LL Yuan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Activation of the BK (SLO1) potassium channel by mallotoxin
SI Zakharov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The protein kinase Cβ-selective inhibitor, enzastaurin (LY317615.HCI), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts
JR Graff et al.
CANCER RESEARCH (2005)
The protein kinase C inhibitor, bisindolylmaleimide (I), inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells
WS Park et al.
LIFE SCIENCES (2005)
The aminosteroid phospholipase C antagonist U-73122 (1-[6-[[17-β-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione) potently inhibits human 5-lipoxygenase in vivo and in vitro
C Feisst et al.
MOLECULAR PHARMACOLOGY (2005)
The protein kinase inhibitor, staurosporine, inhibits L-type Ca2+ current in rabbit atrial myocytes
JH Ko et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Staurosporine inhibits voltage-dependent K+ current through a PKC-independent mechanism in isolated coronary arterial smooth muscle cells
WS Park et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Inhibition of L-type Cav1.2 Ca2+ channels by 2,(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) and 2-[1-(3-dimethyl-aminopropyl)-5-methoxyindol-3-yl]-3-(1H-indol-3-yl) maleimide (Go6983)
A Welling et al.
MOLECULAR PHARMACOLOGY (2005)
In vivo activity of a phospholipase C inhibitor, 1-(6-((17β-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in acute and chronic inflammatory reactions
CF Hou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Protein kinase inhibitors: Insights into drug design from structure
MEM Noble et al.
SCIENCE (2004)
Direct block by bisindolylmaleimide of the voltage-dependent K+ currents of rat mesenteric arterial smooth muscle
A Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Regulation of protein kinases: Controlling activity through activation segment conformation
B Nolen et al.
MOLECULAR CELL (2004)
Localized effects of cAMP mediated by distinct routes of protein kinase A
K Tasken et al.
PHYSIOLOGICAL REVIEWS (2004)
Chelerythrine and bisindolylmaleimide I prolong cardiac action potentials by protein kinase C-independent mechanism
S Voutilainen-Myllylä et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Role of nitric-oxide synthase, free radicals, and protein kinase C δ in opioid-induced cardioprotection
HY Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Protein kinases - the major drug targets of the twenty-first century?
P Cohen
NATURE REVIEWS DRUG DISCOVERY (2002)
Structural aspects of protein kinase control - role of conformational flexibility
RA Engh et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 Å resolution
YF Zhou et al.
NATURE (2001)
Genistein, a soybean isoflavone, inhibits inward rectifier K+ channels in rat osteoclasts
F Okamoto et al.
JAPANESE JOURNAL OF PHYSIOLOGY (2001)
Inhibition of acetylcholine-activated K+ current by chelerythrine and bisindolylmaleimide I in atrial myocytes from mice
H Cho et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Inhibition of Kv1.3 channels by H-89 (N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide) independent of protein kinase A
JS Choi et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Resurgence of sodium channel research
AL Goldin
ANNUAL REVIEW OF PHYSIOLOGY (2001)
Inactivation of Ca2+ action potential channels by the MEK inhibitor PD98059
MC Gould et al.
EXPERIMENTAL CELL RESEARCH (2000)
Inhibition of voltage-dependent sodium channels by Ro 31-8220, a 'specific' protein kinase C inhibitor
R Lingameneni et al.
FEBS LETTERS (2000)
From ionic currents to molecular mechanisms: The structure and function of voltage-gated sodium channels
WA Catterall
NEURON (2000)
Blocker protection in the pore of a voltage-gated K+ channel and its structural implications
D del Camino et al.
NATURE (2000)
Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein
ZH Zhang et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2000)
分享论文
